Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients
Clinical trial NCT02345863 · COMPLETED
Trial details
- NCT number
- NCT02345863
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-16
- Primary completion
- 2016-08-22
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.